Clinical guideline on topical growth factors for skin wounds

Abstract

An increased number of patients with skin wounds have been witnessed in the past decades. Among the various kinds of treatments for skin wounds, topical exogenous growth factors are indispensable and have been used in many countries. However, whether they have reliable effects remains controversial, and their application for skin wound treatment needs to be further standardized and optimized in terms of socio-economic considerations. Thus, the Chinese Burn Association developed this guideline indicating efficacy, application details, adverse reactions and precautions of five clinically common topical growth factors using the Grading of Recommendations Assessment Development and Evaluation method to promote the rational application of topical exogenous growth factors in skin wounds and to benefit more patients.

Keywords

Growth factor / Skin wound / Wound healing / GRADE method / Guideline

References

[1] Sun X, Xie T. Research and related therapies of growth factors in wound healing (Chinese) [J]. J Trauma Surg. 2016; 18: 190-3.

[2] Chen Y, Yao L, Norris S, Du L, Chen H, Zeng X, et al. Application of GRADE in systematic reviews: necessity, frequently asked questions and concerns (Chinese)[J]. Chin J Evid-based Med. 2013; 13: 1401-4.

[3] Zeng X, Leng W, Li S, Guo Y, Wang P. How to understand and use GRADE system correctly? A briefly outline (Chinese) [J]. Chin J Evid-based Med. 2011; 11: 985-90.

[4] Wang S, Cui X, Fu X, Zhou L, Ma J, Yan S. Recombinant human basic fibroblast growth factor in treating burns and other skin injuries (Chinese) [J]. Chin J Traumatol. 1999; 15: 196-9.

[5] Zhang C, Hong S, Gu C, Huang Z, Du S. Clinical observation of recombinant bovine basic fibroblast growth factor in treating second degree burn wounds (Chinese) [J]. Chin J Burns. 2001; 17: 246-6.

[6] Li X, Hong A, Xu H, Yao C, Fu X, Lin J. The clinical study of recombinant bovine basic fibroblast growth factor on wound healing (Chinese) [J]. Journal of Jinan University (Medicine Edition) 2002; 23: 22-7.

[7] Li Z, Huang L, Yang X, Wang C. Application of basic fibroblast growth factor on burn surface (Chinese) [J]. Acad J Sec Mil Med Univ. 2004; 25: 349-9.

[8] Liu Y, Fu Y. Healing effect of bFGF on burn wound degree II of children (Chinese) [J]. Journal of Pediatric Pharmacy. 2005; 4: 20-1.

[9] Fu X, Shen Z, Chen Y, Xie J, Guo Z, Zhang M, et al. Ran-domised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns [J]. Lancet. 1998; 352: 1661-4.

[10] Ye L, Ma J. Therapeutic effects of Befuji (recombinant bovine bFGF solution) on skin wounds and major joint mobility of burn patients (Chinese) [J]. Chinese Journal of Clinical Rehabilitation. 2002; 6: 543-3.

[11] Sun R, Zhao L, Sun J, Li D, Huai Q, Xu L. Clinical observation of modified chitin combined with recombinant human basic fibroblast growth factor in treating superficial partial-thickness burn wound (Chinese) [J]. Chin J Injury Repair and Wound Healing 2018; 13: 269-72.

[12] Liu H, Chen W, Xu H, Hu J, Zhang X. Combined application of EGF and bFGF on early deep partial-thickness burns (Chinese) [J]. Guangdong Medical Journal. 2009; 30: 800-1.

[13] Nie K, Li P, Zeng X, Sun G, Jin W, Wei Z, et al. Clinical obser-vation of basic fibroblast growth factor combined with topical oxygen therapy in enhancing burn wound healing (Chinese) [J]. Chinese Journal of Reparative and Reconstructive Surgery. 2010; 24: 643-6.

[14] Hayashida K, Akita S. Quality of pediatric second-degree burn wound scars following the application of basic fibroblast growth factor: results of a randomized, controlled pilot study [J]. Ostomy Wound Manage. 2012; 58: 32-6.

[15] Yao Y, Fei C, Li Z, Wei W, Wang Y. A comparative study on wound healing treated by different doses of bovine basic fibroblast growth factor (Chinese) [J]. Chin J Burns 2001; 17: 10-2.

[16] Hu Y, Guo S, Lu K, Yang Z. Application of basic fibroblast growth factor on the abrasion of face (Chinese) [J]. Chinese Journal of Aesthetic Medicine. 2001; 10: 114-5.

[17] Sone P, Xue B, Ding Y, Yang J. Comparison of three different treatments for unhealing abdominal incisions (Chinese) [J]. Journal of Chongqing Medical University. 2011; 36: 1400-1.

[18] Zhao Z, Jing Z, Bao J, Zhao J, Qu L, Lu Q. Effect of basic fibroblast growth factor on the incision healing of vascular surgery (Chinese) [J]. Chin J Gen Surg. 2001; 16: 27-8.

[19] Cheng W, Wang Z, Yang W, He J, Yuan J. Therapeutic effects of topical recombinant bovine basic fibroblast growth factor spray on maxillofacial soft tissue abrasion (Chinese) [J]. Clinical Medicine. 2011; 31: 37-8.

[20] Fu X, Shen Z, Chen Y, Xie J, Guo Z, Zhang M, et al. Basic fibroblast growth factor (bFGF) and wound healing, a multi-center and controlled clinical trial in 1024 cases (Chinese) [J]. Chinese J Reparative and Reconstructive Surgery. 1998; 12: 209-11.

[21] Chen Q, Li J, Yao J, Wu S, Shen X, Song Z, et al. The clinical observation of the basic fibroblast growth factor on skin graft donor site (Chinese) [J]. Journal of Practical Aesthetic and Plastic Surgery. 2001; 12: 302-4.

[22] Wu J, Fu Z, Chen W, Gu S, Yang J. Therapeutic effect of basic fibroblast growth factor on the wound healing of skin graft donor site (Chinese) [J]. The Journal of Practical Medicine. 2003; 19: 1145-6.

[23] Wang Q, Hu Q, Liu D. Effect of basic fibroblast growth factor treatment on skin graft donor site with different application methods (Chinese) [J]. Sichuan Medical Journal. 2010; 31: 214-5.

[24] Fu X, Guo Z, Sheng Z. Effects of basic fibroblast growth factor on the healing of cutaneous chronic wounds (Chinese) [J]. Chinese J Reparative and Reconstructive Surgery. 1999; 13: 270-2.

[25] Rong Z, Wang L, Ba T. Application of basic fibroblast growth factor on chronic refractory wound (Chinese) [J]. Chin J Exp Clin Infect Dis (Electronic Edition) 2012; 6: 580-2.

[26] Pan D, Ye G, Wu C, Xu S, Wang S, Qin Y. Prosthetic effect of recombinant human basic fibroblast growth factor combined with silvadene cream on the healing of chronic and refractory wound (Chinese) [J]. Journal of Wenzhou Medical University. 2014; 44: 294-6.

[27] Fu X, Shen Z, Guo Z, Zhang M, Sheng Z. Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor (Chinese) [J]. Chin Med J (English). 2002; 115: 331-5.

[28] Le J, Jiang J, Wu J. Effect of basic fibroblast growth factor on the healing of cutaneous burn wounds in diabetes patients (Chinese) [J]. Acta Univ Med Tongji 2000; 29: 545-6.

[29] Chen Q, Ou J, Xin W, Bi Y. Effects of recombinant bovine basic fibroblast growth factor combined with alginate dressing on chronic ulcers of elderly patients (Chinese) [J]. Modern Medical Journal. 2011; 39: 412-6.

[30] Zheng H, Fang F, Chen W, Liu L, Feng X, Xu J. Treatment of diabetic foot disease by recombinant bovine basic fibrob-last growth factor: randomized controlled observation on the therapeutic effect (Chinese) [J]. Chinese Journal of Clinical Rehabilitation. 2004; 8: 6564-5.

[31] Richard J, Parer-Richard C, Daures J, Clouet S, Vannereau D, Bringer J, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study [J]. Diabetes Care. 1995; 18: 64-9.

[32] Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009; 19: 461-8.

[33] Zhang C, Yang J, Feng Y, Wang H, Li X, Chen N. Clinical observation of negative pressure wound therapy and basic fibroblast growth factor in the treatment of intractable pressure ulcer (Chinese) [J]. Natl Med J China. 2012; 92: 2862-4.

[34] Robson M, Phillips L, Lawrence W, Bishop J, Youngerman J, Hayward P, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores[J]. Ann Surg. 1992; 216: 401-6 discus-sion 406-8.

[35] Ohura T, Nakajo T, Moriguchi T, Oka H, Tachi M, Ohura N, Jr et al. Clinical efficacy of basic fibroblast growth factor on pressure ulcers: case-control pairing study using a new evalua-tion method [J]. Wound Repair Regen. 2011; 19: 542-51.

[36] Robson M, Hill D, Smith P, Wang X, Meyer-Siegler K, Ko F, et al. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response [J]. Ann Surg. 2000; 231: 600-11.

[37] Gan L, Fu Y. Healing effect of bFGF on thin-partial-thickness grafting of children (Chinese) [J]. Journal of Pediatric Phar-macy. 2005; 11: 19-20.

[38] He X, Zeng X. Application of Beifuji on split thin-partial-thickness autografting of medium thickness skin donor sites (basic fibroblast growth factor) (Chinese) [J]. Practical Clinical Medicine. 2008; 9: 65-6.

[39] He L, Liu H, Xu Y. Li and Sun D. treatment of basic fibroblast growth factor on skin wounds in 65 cases (Chinese) [J]. Chin J Traumatol. 2000; 16: 135.

[40] Zhang S, Han C. Therapeutic effects of basic fibroblast growth factor on CO₂ laser treated wounds (Chinese) [J]. Chin J Dermatol. 2001; 34: 141-2.

[41] Dai X. Recombinant basic fibroblast growth factor in the treatment of II◦ acute radiodermatitis (Chinese) [J]. Journal of Chongqing Medical University. 2001; 26: 337.

[42] Ma B, Cheng D, Xia Z, Ben D, Lu W, Cao Z, et al. Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site [J]. Wound Repair Regen. 2007; 15: 795-9.

[43] Cui F, Xu Q, Zheng H. Treatment of acidic fibroblast growth factor on medium and small sized deep-partial-thickness burns (Chinese) [J]. Chin J Hemorh. 2012; 22: 291.

[44] Chai J, Sun Y, Xia Z, Liao Z, Chen H, Shen C, et al. A randomized, multi-center and parallel control trial for acidic fibroblast growth factor in the treatment of deep second degree burn (Chinese) [J]. China Pharmacist. 2015; 18: 589-91.

[45] Zhang J, Xu Q, Zhang F. Application of acidic fibroblast growth factor on residual burn wounds (Chinese) [J]. Chin J Hemorh. 2012; 22: 292-3.

[46] Liu F, Jiang Z, Yang J, Geng S, Zhang S, Yin L, et al. Treatment of human acidic fibroblast growth factor on diabetic foot ulcers in 23 cases (Chinese) [J]. Chinese Journal of Surgery of Integrated Traditional and Western Medicine. 2004; 10: 424-5.

[47] Li H, Liang Z, Meng C, Li D. The efficacy and safety of recombinant human epidermal growth factor in 4 types of wounds (Chinese) [J]. Chinese Journal of New Drugs. 2003; 13: 1048-50.

[48] Wang S, Guo Z, Zhou L, Zhou Y, Liu X, Zhou H, et al. Effects of recombinant human epidermal growth factor on the healing of burn wounds (Chinese) [J]. Chin J Clin Pharmacol. 1998; 14: 150-4.

[49] Li C, Yu D, Qin F, Chen Z, Sun Y. Clinical experiment study of epidermal growth factor (EGF) on the promotion of burns wound healing (Chinese) [J]. Chin J Clin Pharmacol. 2001; 17: 27-30.

[50] Zhou L, Wang S, Ma J, Chai J, Xu M. Recombinant human epidermal growth factor in treatment of 100 cases of burn wounds (Chinese) [J]. Chinese New Drugs Journal. 2000; 9: 399-401.

[51] Zhou L, Wang S, Ma J, Chai J, Li L. A multi-center clinical trial of topical recombinant human epidermal growth factor on burn wounds (Chinese) [J]. Chin J New Dugs Clin Rem. 2000; 1: 337-40.

[52] Guo X, Tan M, Guo L, Xiong A, Li Y, He X. Clinical study on repair of burn wounds of degree II with recombinant human epidermal growth factor in elderly patients (Chinese) [J]. Chin J Reparative Reconstructive Surgery. 2010; 24: 462-4.

[53] Li X, Zhao B, Qian L, Wu Z. Clinical observation of healing efficacy of recombinant human epidermal growth factor in treatment of burn wounds (Chinese) [J]. China Journal of Modern Medicine. 2005; 15: 2683-5.

[54] Peng W, Yu J, Shu H. Effects of recombinant human epidermal growth factor on the healing of second degree burn wounds (Chinese) [J]. Guangdong Medical Journal. 2002; 23: 75-6.

[55] Tan J, Zhang B, Yu L, Li W. The role of topical recombinant human epidermal growth factor on the healing of second degree burn wounds (Chinese) [J]. Journal of Practical Medicine. 2001; 17: 872-3.

[56] Wang J, Li J, Zhang G, Wu X, Wei T, Chen J. Clinical observa-tion of epidermal growth factor on wound repair (Chinese) [J]. Chin Hosp Pharm J. 2001; 21: 296-7.

[57] Liu X, Huang Y, Wang J, Yang Z. Relationship between improving burn wound management and raising cure rate (Chi-nese) [J]. Acta Academiae Medicinae Militaris Tertiae. 2000; 22: 1197-200.

[58] Liang Z, Li H, Meng C, Sun X. A comparison of repaired effect of recombinant human epidermal growth factor for the facial degree II burn wounds (Chinese) [J]. Chinese Journal of New Drugs. 2006; 15: 812-4.

[59] Yi C, Chen Y, Wei D, Lu W, Huan J, Ben D. Accel-eration of II degree burn wound healing with topical application of recombinant human epidermal growth factor (Chinese) [J]. Chinese Journal of Traumatology. 1998; 14: 350-2.

[60] Wang Z, Ge L, Rong X, Wei H, Liu L, Yang R, et al. Irra-diated pigskin graft dressing and recombinant human epider-mal growth factor gel application in treatment of small-area partial-thickness burn: report of 135 cases (Chinese) [J]. Acta Academiae Medicinae Militaris Tertiae. 2010; 32: 71-3.

[61] Wang G, Xia Z, Zhu S, Tang H, Huan J, Chen Y, et al. Clinical observation of the long-term effects of rhEGF on deep partial-thickness burn wounds (Chinese) [J]. Chin J Burns. 2003; 19: 167-8.

[62] Zhou Z, Huang X. Effect of recombinant human epidermal growth factor gel combined with nano silver dressing on total bacterial culture positive rate and healing time in patients with deep second degree burn wounds. Chin J Ctrl Endem Dis. 2017; 32: 1400.

[63] Zhang X, Ding X, Lin X, Yang P, Lin K. Clinical observation of recombinant human epidermal growth factor combined with lipoic acid in the treatment of diabetic foot (Chinese) [J]. China Pharmacy. 2016; 27: 4147-9.

[64] Wei L, Sun S, Song G, Chen S. The efficacy and safety of recom-binant human epidermal growth factor combined with ionic silver dressing intreatment of diabetic foot ulcers (Chinese) [J]. Chinese General Practice. 2011; 14: 1637-9.

[65] Afshari M, Larijani B, Fadayee M, Ghahary A, Pajouhi M, Bastanhagh M, et al. Efficacy of topical epidermal growth factor in healing diabetic foot ulcers [J]. Therapy. 2005; 2: 759-65.

[66] Gomez-Villa R, Aguilar-Rebolledo F, Lozano-Platonoff A, Teran-Soto J, Fabian-Victoriano M, Kresch-Tronik N, et al. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial [J]. Wound Repair Regen. 2014; 22: 497-503.

[67] Tsang M, Wong W, Hung C, Lai K, Tang W, Cheung E, et al. Human epidermal growth factor enhances healing of diabetic foot ulcers [J]. Diabetes Care. 2003; 26: 1856-61.

[68] Song R, Shen K, Ma H, Ren L. Epidermal growth factor combined with silver ion dressing treatment for diabetic foot infections in clinical research (Chinese) [J]. Chinese Journal of Nosocomiology. 2014; 24: 4033-5.

[69] Liu K, Xu L, Wang L. Observing the clinical effect of rhEGF for treating diabetes patients skin infection (Chinese) [J]. Chinese Pharmacological Bulletin. 2005; 21: 1535-6.

[70] Park K, Han SH, Hong J, Han SK, Lee D, Kim B, et al. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double-blind, ran-domized, placebo-controlled trial [J]. Diabetes Research and Clinical Practice. 2018; 142: 335-44.

[71] Xue L, Lu M, Feng L, Zhu W, Li W, Jiang M, et al. Local treatment of venous leg ulceration with rhEGF (Chinese) [J]. Chinese Journal of Experimental Surgery. 1998; 15: 124-5.

[72] Falanga V, Eaglstein W, Bucalo B, Katz M, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers [J]. J Dermatol Surg Oncol. 1992; 18: 604-6.

[73] Doerler M, Eming S, Dissemond J, Wolter A, Stoffels-Weindorf M, Reich-Schupke S, et al. A novel epidermal growth factor-containing wound dressing for the treatment of hard-to-heal venous leg ulcers [J]. Adv Skin Wound Care. 2014; 27: 456-60.

[74] Yu W, Liu C. Effects of recombinant human epidermal growth factor on the healing of ota mole laser-treated wounds (Chi-nese) [J]. Guangdong Medical Journal. 2003; 24: 270-1.

[75] Ju M, Zheng Z, Zhang X, Chen Q, Yang X, Cao N, et al. Clinical observation of recombinant human epidermal growth factor on wound healing (Chinese) [J]. Chinese Journal of Dermatology. 2002; 35: 237.

[76] Techapichetvanich T, Wanitphakdeedecha R, Iamphonrat T, Phothong W, Eimpunth S, Hidajat I, et al. The effects of recom-binant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: a split-face randomized controlled study [J]. Journal of Cosmetic Dermatology. 2018; 17: 756-61.

[77] Li S, Gao L, Yin W, Xu G, Xiao G. Effect of gene time on acute radiation mucositis and dermatitis (Chinese) [J]. Chinese Jounal of Radiation Oncology. 2002; 11: 30-2.

[78] Hemanthi R. Role of recombinant human epidermal growth factor in wound healing of chronic leg ulcers [J]. International Journal of Scientific Research. 2018; 7: 59.

[79] Kaplan G, Walsh G, Guido LS, Meyn P, Burkhardt RA, Abalos RM, et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating fac-tor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med. 1992; 175(6): 1717-28.

[80] Yan H, Chen J, Peng X. Recombinant human granulocyte macrophage colony-stimulating factor hydrogel promotes heal-ing of deep partial thickness burn wounds [J]. Burns. 2012; 38: 877-81.

[81] Zhang L, Chen J, Han C. A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns [J]. Wound Repair Regen. 2009; 17: 685-9.

[82] Chi Y, Chai J, Luo H, Zhang Q, Feng R. Safety of recombinant human granulocyte-macrophage colony-stimulating factor in healing pediatric severe burns [J]. Genet Mol Res. 2015; 14: 2735-41.

[83] Wang Z, Zhang Q, Liao Z, Han C, Lv G, Luo C, et al. Effect of recombinant human granulocyte-macrophage colony stimulating factor on wound healing in patients with deep partial thickness bum (Chinese) [J]. Chin J Burns. 2008; 24: 107-10.

[84] Lin Y, Chen M, Ding F, Wang R, Liang Z, Meng C, et al. Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn [J]. Burns. 2015; 41: 1086-91.

[85] Qu K. Effects of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel on healing of deep partial-thickness burn wounds and its mechanism analysis (Chinese)[D]. Qingdao, China: University of Qingdao, 2017.

[86] Yan D, Liu S, Zhao X, Bian H, Yao X, Xing J, et al. Recombi-nant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healing [J]. Medicine. 2017; 96: 22.

[87] Qiu X, Wang J, Yang L, Ren J. A comparative study of topical rhGM-CSF with rhEGF on residual burn wounds (Chinese) [J]. Guangdong Medical Journal. 2013; 34: 956-8.

[88] Shi C.Recombinant human granulomacrophage colony-stimulating factor gel on residual burn wounds (Chinese) [J]. Shanxi Medical Journal. 2012; 41: 882-3.

[89] Huang G, Sun T, Zhang L, Wu Q, Zhang K, Tian Q, et al. Com-bined application of alginate dressing and human granulocyte-macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers [J]. Exp Ther Med. 2014; 7: 1772-6.

[90] Steed D.Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic ulcer study group [J]. J Vasc Surg. 1995; 21: 71-8 discussion 79-81.

[91] Wieman T and Becaplermin Gel Studies Group. Clinical effi-cacy of becaplermin (rhPDGF-BB) gel [J]. Am J Surg. 1998; 176: 74-9.

[92] Jaiswal S, Gambhir R, Agrawal A, Harish S. Efficacy of topical recombinant human platelet derived growth factor on wound healing in patients with chronic diabetic lower limb ulcers [J]. Indian J Surg. 2010; 72: 27-31.

[93] Mustoe T, Cutler N, Allman R, Goode P, Deuel T, Prause J, et al. A phase II study to evaluate recombinant platelet-derived growth factor-bb in the treatment of stage 3 and 4 pressure ulcers [J]. Arch Surg. 1994; 129: 213-9.

[94] Rees R, Robson M, Smiell J, Perry B. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study [J]. Wound Repair Regen. 1999; 7: 141-7.

[95] Robson M, Phillips L, Thomason A, Robson L, Pierce G. Platelet-derived growth factor bb for the treatment of chronic pressure ulcers [J]. Lancet. 1992; 339: 23-5.

[96] Zhang M. The study of the clinical effects of external use of recombinant human acidic fibroblast growth factor (rhaFGF) on the burn and poor healing wound in children (Chi-nese) [J]. China & Foreign Medical Treatment. 2014; 10: 29-30.

[97] Liu Y, Liu J, Li Y. Study on promotion effect of recombinant human acidic fibroblast growth factor on wound healing in children by multicenter randomized controlled trials (Chinese) [J]. China Pharmacist 2015; 18: 77-9.

[98] Xu F, He M, Yang F. The clinical effect of recombinant bovine basic fibroblast growth factor promoting wound healing after burn (Chinese) [J]. Chin J of Clinical Rational Drug Use. 2016; 9: 35-6.

[99] Liu Z, Xia Z, Tang H, Yang Y. Curative effects of recombinant bovine basic fibroblast growth factor gel on II degree burn wound (Chinese) [J]. Academic Journal of Second Military Medical University. 2004; 25: 1270-1.

[100] Zheng Z, Liu J, Xie W, Wu R, Zhou H, Wan S. Application of recombinant human epidermal growth factor in the treat-ment of children with II degree burn (Chinese) [J]. Journal of Huazhong University of Science and Technology (Health Sciences) 2003; 32: 667-8.

[101] Li W, Deng L. Clinical efficacy of the usage of rhEGF in combination with recombinant b-FGF on the treatment of patients with pressure ulcer (Chinese) [J]. Chinese Journal of Hospital Pharmacy. 2013; 33: 1517-9.

[102] Tang Y, Zhang C, Liu Y, Tian Y. Observation of treatment of recombinant human epidermal growth factor combined with Rifampin Vaseline gauze on residual burn wounds (Chinese) [J]. Guangdong Medical Journal. 2009; 30: 1730-2.

[103] Liao Y, Guo L, Ding E, He X, Xie X, Xia D. A comparative study on burn wound healing treated by different methods of recombinant human epidermal growth factor (Chinese) [J]. Chin J Reparative and Reconstructive Surgery. 2003; 17: 301-2.

[104] Zhang X, Li H, Xu B, Liu S, Zhou X. The effective-ness of recombinant human epidermal growth factor gel together with infrared radiation in the treatment of pressure ulcer (Chinese) [J]. Chinese Journal of Nursing. 2009; 44: 937-8.

[105] Wang S, Deng S, Ma J, Zhu J, Li L, Liao Z, et al. To compare the clinical healing efficacy of recombinant human epidermal growth factor of different form of drug in treatment of burn wounds (Chinese) [J]. The Chinese Journal of Clinical Pharma-cology. 2002; 18: 12-4.

[106] Wang S, Ma J, Zhou L, Liao Z, Deng S, Li L, et al. Effect of recombinant Hunan epidermal growth factor (EGF) cream on EGF concentration in serum of patients (Chinese) [J]. The Chinese Journal of Clinical Pharmacology. 2003; 19: 174-7.

[107] Wang S, Ma J, Chai J, Zhou L, Liao Z, Huang Y, et al. Acceleration of burn wound healing with topical application of recombinant human epidermal growth factor ointments (Chinese) [J]. Chin J Reparative Reconstructive Surgery. 2002; 16: 173-6.

[108] Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recur-rence of chronic venous ulcers [J]. Int J Dermatol. 1999; 38: 380-6.

[109] Zeng H. Effects of recombinant human epidermal growth factor wet dressing on II-III stage pressure sore after stroke (Chinese) [J]. Chinese Journal of Rehabilitation Theory and Practice. 2011; 17: 292-3.

[110] Wang S, Zhou L, Ma J. Experimental observation on ADRs of recombinant human epidermal growth factor (rhEGF) in healthy and burned volunteers (Chinese) [J]. Chinese Journal of New Drugs. 2000; 9: 34-6.

[111] Wang S, Zhou L, Li L, Ma J, Chai J, Deng S, et al. Safety researches of recombinant human epidermal growth factor (rhEGF) cream in treating burns (Chinese) [J]. The Chinese Journal of Clinical Pharmacology. 2001; 17: 268-71.

[112] Prada M, Roa C, Alfonso P, Acero G, Huérfano L, Vivas-Consuelo D. Cost-effectiveness analysis of the human recom-binant epidermal growth factor in the management of patients with diabetic foot ulcers [J]. Diabetic Foot & Ankle 2019; 1480249: 1-7.

[113] Gilligan A, Waycaster C, Milne C. Cost-effectiveness of becaplermin gel on wound closure for the treatment of pressure injuries [J]. Wounds. 2018; 30: 174-81.